content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <cik>0001976247</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001720893</issuerCik>
        <issuerName>BioXcel Therapeutics, Inc.</issuerName>
        <secFileNumber>001-38410</secFileNumber>
        <issuerAddress>
          <com:street1>555 LONG WHARF DRIVE</com:street1>
          <com:city>NEW HAVEN</com:city>
          <com:stateOrCountry>CT</com:stateOrCountry>
          <com:zipCode>06511</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>203-643-8060</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Mueller Family 2010 Irrevocable Trust</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>Affiliate</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>common</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>Cowen and Company, LLC</name>
          <address>
            <com:street1>599 Lexington Ave</com:street1>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10022</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>2500</noOfUnitsSold>
        <aggregateMarketValue>50000.00</aggregateMarketValue>
        <noOfUnitsOutstanding>29159638</noOfUnitsOutstanding>
        <approxSaleDate>06/20/2023</approxSaleDate>
        <securitiesExchangeName>nasdaq</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>common</securitiesClassTitle>
        <acquiredDate>03/08/2018</acquiredDate>
        <natureOfAcquisitionTransaction>purchased in public market</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>BioXcel Therapeutics</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>2500</amountOfSecuritiesAcquired>
        <paymentDate>03/08/2018</paymentDate>
        <natureOfPayment>Purchased in Public Market</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <noticeSignature>
        <noticeDate>06/20/2023</noticeDate>
        <planAdoptionDates>
          <planAdoptionDate>03/21/2023</planAdoptionDate>
        </planAdoptionDates>
        <signature>/s/ Charles Platt</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 2881}]
text: 144
  0001976247
  XXXXXXXX
  LIVE
  0001720893
  BioXcel Therapeutics, Inc.
  001-38410
  555 LONG WHARF DRIVE
  NEW HAVEN
  CT
  06511
  203-643-8060
  Mueller Family 2010 Irrevocable Trust
  Affiliate
  common
  Cowen and Company, LLC
  599 Lexington Ave
  New York
  NY
  10022
  2500
  50000.00
  29159638
  06/20/2023
  nasdaq
  common
  03/08/2018
  purchased in public market
  BioXcel Therapeutics
  N
  2500
  03/08/2018
  Purchased in Public Market
  Y
  06/20/2023
  03/21/2023
  /s/ Charles Platt